Starts in March 2022
Felix Deku is a biomedical engineer whose research focuses on developing novel materials and fabrication processes that enable the seamless integration of microelectronics with the nervous system. These human-machine interfaces have allowed paralyzed or tetraplegic patients to physically interact with their environment. Work in these areas could lead to therapies for neurological disorders and neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, and chronic pain.
Deku currently oversees electrode engineering at Braingrade, a company developing brain-computer interfaces for cognitive enhancement, and neuromodulation therapies for Alzheimer’s Disease and Dementia patients. Before that, he spent three years working at Neuralink, a Bay-Area company also focused on machine-human interfaces. In his role as the Director of Microfabrication, Deku provided technical leadership on electrode design innovation, advanced manufacturing technology, electrode material development, characterization and testing, as well as high volume manufacturing.
Deku earned his doctorate and master’s degrees in biomedical engineering from the University of Texas at Dallas. He earned his bachelor’s degree in molecular biology and biotechnology from the University of Cape Coast in Ghana.